William P. Katt

2.0k total citations
38 papers, 1.5k citations indexed

About

William P. Katt is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William P. Katt has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William P. Katt's work include Cancer, Hypoxia, and Metabolism (14 papers), Blood properties and coagulation (5 papers) and ATP Synthase and ATPases Research (5 papers). William P. Katt is often cited by papers focused on Cancer, Hypoxia, and Metabolism (14 papers), Blood properties and coagulation (5 papers) and ATP Synthase and ATPases Research (5 papers). William P. Katt collaborates with scholars based in United States, India and Canada. William P. Katt's co-authors include Richard A. Cerione, Michael J. Lukey, Andrew D. Hamilton, Nathan T. Ross, Sekar Ramachandran, Marc A. Antonyak, Saı̈d M. Sebti, Jon W. Erickson, Matthew P. Glenn and Patrick T. Gunning and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

William P. Katt

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William P. Katt United States 22 946 602 315 213 147 38 1.5k
Gillian Paine-Murrieta United States 16 1.4k 1.5× 545 0.9× 323 1.0× 137 0.6× 185 1.3× 18 2.1k
Shingo Dan Japan 26 1.4k 1.5× 294 0.5× 493 1.6× 278 1.3× 191 1.3× 95 2.3k
D. Lynn Kirkpatrick United States 18 1.4k 1.4× 436 0.7× 282 0.9× 224 1.1× 189 1.3× 34 1.8k
Chad N. Hancock United States 12 1.0k 1.1× 637 1.1× 252 0.8× 77 0.4× 74 0.5× 16 1.4k
Marc O’Reilly United Kingdom 15 1.0k 1.1× 368 0.6× 219 0.7× 137 0.6× 82 0.6× 20 1.3k
Daniel Verduzco United States 11 1.1k 1.1× 658 1.1× 442 1.4× 113 0.5× 140 1.0× 13 1.9k
Xiaonan Zhang Sweden 21 1.2k 1.3× 383 0.6× 475 1.5× 156 0.7× 96 0.7× 65 1.9k
Leticia G. León Spain 25 1.2k 1.3× 842 1.4× 650 2.1× 429 2.0× 165 1.1× 77 2.2k
Frederik B. Pruijn New Zealand 25 791 0.8× 729 1.2× 297 0.9× 364 1.7× 142 1.0× 57 1.7k
Esther A. Zaal Netherlands 16 922 1.0× 402 0.7× 255 0.8× 51 0.2× 102 0.7× 42 1.3k

Countries citing papers authored by William P. Katt

Since Specialization
Citations

This map shows the geographic impact of William P. Katt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Katt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Katt more than expected).

Fields of papers citing papers by William P. Katt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Katt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Katt. The network helps show where William P. Katt may publish in the future.

Co-authorship network of co-authors of William P. Katt

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Katt. A scholar is included among the top collaborators of William P. Katt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Katt. William P. Katt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katt, William P., Cheryl E. Balkman, Michael Byron, et al.. (2025). Clinical application of the MEK inhibitor trametinib in dogs with oral squamous cell carcinoma. 2(1).
2.
Greene, Kai Su, Ruizhi Li, Yijian Qiu, et al.. (2024). Glutamine metabolism is essential for coronavirus replication in host cells and in mice. Journal of Biological Chemistry. 301(1). 108063–108063. 1 indexed citations
3.
Pabit, Suzette A., et al.. (2024). Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death. Communications Biology. 7(1). 982–982. 2 indexed citations
4.
Peralta, Santiago, et al.. (2023). Confirmation of canine acanthomatous ameloblastoma using RAS Q61R immunohistochemical staining of formalin-fixed paraffin-embedded tissues. Frontiers in Veterinary Science. 10. 1281022–1281022. 1 indexed citations
5.
Katt, William P., et al.. (2022). Alone and Together: Current Approaches to Targeting Glutaminase Enzymes As Part of Anti-Cancer Therapies. PubMed. 4(4). FDD79–FDD79. 14 indexed citations
6.
Milano, Shawn K., Qingqiu Huang, Sekar Ramachandran, et al.. (2021). New insights into the molecular mechanisms of glutaminase C inhibitors in cancer cells using serial room temperature crystallography. Journal of Biological Chemistry. 298(2). 101535–101535. 24 indexed citations
7.
Peralta, Santiago, G Duhamel, William P. Katt, et al.. (2021). Comparative transcriptional profiling of canine acanthomatous ameloblastoma and homology with human ameloblastoma. Scientific Reports. 11(1). 17792–17792. 8 indexed citations
8.
Singleton, Dean C., et al.. (2020). Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer. BMC Cancer. 20(1). 470–470. 29 indexed citations
9.
Lukey, Michael J., Ahmad A. Cluntun, William P. Katt, et al.. (2019). Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer. Cell Reports. 29(1). 76–88.e7. 75 indexed citations
10.
McDermott, Lee, David Ryan Koes, Shabber Mohammed, et al.. (2019). GAC inhibitors with a 4-hydroxypiperidine spacer: Requirements for potency. Bioorganic & Medicinal Chemistry Letters. 29(19). 126632–126632. 8 indexed citations
11.
Katt, William P., Marc A. Antonyak, & Richard A. Cerione. (2018). Opening up about Tissue Transglutaminase: When Conformation Matters More than Enzymatic Activity. SHILAP Revista de lepidopterología. 3(6). 18 indexed citations
12.
Katt, William P., Marc A. Antonyak, & Richard A. Cerione. (2018). The diamond anniversary of tissue transglutaminase: a protein of many talents. Drug Discovery Today. 23(3). 575–591. 36 indexed citations
13.
McDermott, Lee, Lawrence A. Vernetti, Jingran Sun, et al.. (2016). Design and evaluation of novel glutaminase inhibitors. Bioorganic & Medicinal Chemistry. 24(8). 1819–1839. 47 indexed citations
14.
Katt, William P. & Richard A. Cerione. (2013). Glutaminase regulation in cancer cells: a druggable chain of events. Drug Discovery Today. 19(4). 450–457. 100 indexed citations
15.
Katt, William P., Sekar Ramachandran, Jon W. Erickson, & Richard A. Cerione. (2012). Dibenzophenanthridines as Inhibitors of Glutaminase C and Cancer Cell Proliferation. Molecular Cancer Therapeutics. 11(6). 1269–1278. 81 indexed citations
16.
Ross, Nathan T., William P. Katt, & Andrew D. Hamilton. (2010). Synthetic mimetics of protein secondary structure domains. Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences. 368(1914). 989–1008. 62 indexed citations
17.
Rodriguez, Johanna M., et al.. (2009). Structure and Function of Benzoylurea‐Derived α‐Helix Mimetics Targeting the Bcl‐xL/Bak Binding Interface. ChemMedChem. 4(4). 649–656. 40 indexed citations
18.
Gunning, Patrick T., Matthew P. Glenn, Khandaker Siddiquee, et al.. (2008). Targeting Protein–Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small‐Molecule, Nonpeptidic SH2 Domain Binders. ChemBioChem. 9(17). 2800–2803. 41 indexed citations
19.
Gunning, Patrick T., William P. Katt, Matthew P. Glenn, et al.. (2007). Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: Structural recognition of STAT SH2 domains. Bioorganic & Medicinal Chemistry Letters. 17(7). 1875–1878. 45 indexed citations
20.
Breneman, Curt M., et al.. (2003). New developments in PEST shape/property hybrid descriptors. Journal of Computer-Aided Molecular Design. 17(2-4). 231–240. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian Paine-Murrieta Breakdown of academic impact, for papers by Shingo Dan Breakdown of academic impact, for papers by D. Lynn Kirkpatrick Breakdown of academic impact, for papers by Chad N. Hancock Breakdown of academic impact, for papers by Marc O’Reilly Breakdown of academic impact, for papers by Daniel Verduzco Breakdown of academic impact, for papers by Xiaonan Zhang Breakdown of academic impact, for papers by Leticia G. León Breakdown of academic impact, for papers by Frederik B. Pruijn Breakdown of academic impact, for papers by Esther A. Zaal
Rankless by CCL
2026